Michael Ashenden

1.7k total citations
26 papers, 1.2k citations indexed

About

Michael Ashenden is a scholar working on Hematology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Ashenden has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 10 papers in Genetics and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Ashenden's work include Erythropoietin and Anemia Treatment (17 papers), High Altitude and Hypoxia (10 papers) and Hormonal and reproductive studies (5 papers). Michael Ashenden is often cited by papers focused on Erythropoietin and Anemia Treatment (17 papers), High Altitude and Hypoxia (10 papers) and Hormonal and reproductive studies (5 papers). Michael Ashenden collaborates with scholars based in Australia, France and Japan. Michael Ashenden's co-authors include Ken Sharpe, Christopher J. Gore, Allan G. Hahn, Geoffrey P. Dobson, Robin Parisotto, Yorck Olaf Schumacher, C. J. Gore, David T. Martin, Kerry R. Emslie and Will G. Hopkins and has published in prestigious journals such as Clinical Chemistry, Sports Medicine and Journal of Clinical Pathology.

In The Last Decade

Michael Ashenden

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ashenden Australia 20 512 507 316 284 207 26 1.2k
Robin Parisotto Australia 13 503 1.0× 423 0.8× 252 0.8× 229 0.8× 168 0.8× 18 1.0k
C Howe Australia 7 162 0.3× 295 0.6× 250 0.8× 165 0.6× 88 0.4× 7 601
Fisher Jw United States 11 44 0.1× 258 0.5× 169 0.5× 36 0.1× 103 0.5× 30 561
Linn Gillberg Denmark 22 257 0.5× 63 0.1× 123 0.4× 12 0.0× 367 1.8× 38 1.4k
Michael Walter Germany 16 31 0.1× 58 0.1× 163 0.5× 18 0.1× 153 0.7× 43 937
Adrian P. Trifa Romania 18 65 0.1× 214 0.4× 33 0.1× 94 0.3× 39 0.2× 84 966
H. Rochman United States 15 136 0.3× 18 0.0× 334 1.1× 63 0.2× 94 0.5× 29 773
Ming Yu China 12 148 0.3× 17 0.0× 122 0.4× 14 0.0× 188 0.9× 39 964
Ehtesham Arif United States 18 164 0.3× 12 0.0× 37 0.1× 72 0.3× 132 0.6× 36 917
Nancy Hua United States 6 34 0.1× 98 0.2× 261 0.8× 66 0.2× 276 1.3× 8 877

Countries citing papers authored by Michael Ashenden

Since Specialization
Citations

This map shows the geographic impact of Michael Ashenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ashenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ashenden more than expected).

Fields of papers citing papers by Michael Ashenden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ashenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ashenden. The network helps show where Michael Ashenden may publish in the future.

Co-authorship network of co-authors of Michael Ashenden

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ashenden. A scholar is included among the top collaborators of Michael Ashenden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ashenden. Michael Ashenden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashenden, Michael, Ken Sharpe, Andrew Garnham, & Christopher J. Gore. (2012). Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma. Journal of Pharmaceutical and Biomedical Analysis. 67-68. 123–128. 11 indexed citations
2.
Ashenden, Michael, et al.. (2012). Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments. Journal of Clinical Pathology. 66(3). 232–237. 6 indexed citations
3.
Ashenden, Michael, et al.. (2011). Current markers of the Athlete Blood Passport do not flag microdose EPO doping. European Journal of Applied Physiology. 111(9). 2307–2314. 80 indexed citations
4.
Ashenden, Michael, et al.. (2011). Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport. Journal of Clinical Pathology. 65(1). 8–13. 3 indexed citations
5.
Macdougall, Iain C. & Michael Ashenden. (2009). Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medications. Advances in Chronic Kidney Disease. 16(2). 117–130. 59 indexed citations
6.
Sharpe, Ken, Michael Ashenden, & Yorck Olaf Schumacher. (2006). A third generation approach to detect erythropoietin abuse in athletes.. PubMed. 91(3). 356–63. 85 indexed citations
7.
Schumacher, Yorck Olaf & Michael Ashenden. (2004). Doping with Artificial Oxygen Carriers. Sports Medicine. 34(3). 141–150. 20 indexed citations
8.
Ashenden, Michael, Ken Sharpe, Rasmus Damsgaard, & Lisa Jarvis. (2004). Standardization of Reticulocyte Values in an Antidoping Context. American Journal of Clinical Pathology. 121(6). 816–825. 2 indexed citations
9.
Nelson, Margaret, et al.. (2003). Proof of homologous blood transfusion through quantification of blood group antigens.. PubMed. 88(11). 1284–95. 60 indexed citations
10.
Ashenden, Michael, Christopher J. Gore, Robin Parisotto, et al.. (2003). Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.. PubMed. 88(9). 1053–62. 32 indexed citations
11.
Nelson, Margaret, et al.. (2002). Detection of homologous blood transfusion by flow cytometry: a deterrent against blood doping.. PubMed. 87(8). 881–2. 35 indexed citations
12.
Gore, Christopher J., et al.. (2002). Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. European Journal of Applied Physiology. 86(5). 442–449. 80 indexed citations
13.
Gore, Christopher J., et al.. (2002). Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. European Journal of Applied Physiology. 86(6). 548–548. 4 indexed citations
14.
Hahn, Allan G., C. J. Gore, David T. Martin, et al.. (2001). An evaluation of the concept of living at moderate altitude and training at sea level. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 128(4). 777–789. 57 indexed citations
15.
Ashenden, Michael, et al.. (2001). A comparison of the physiological response to simulated altitude exposure and r-HuEpo administration. Journal of Sports Sciences. 19(11). 831–837. 34 indexed citations
16.
Ashenden, Michael, Christopher J. Gore, Geoffrey P. Dobson, et al.. (2000). Simulated moderate altitude elevates serum erythropoietin but does not increase reticulocyte production in well-trained runners. European Journal of Applied Physiology. 81(5). 428–435. 67 indexed citations
17.
18.
Ashenden, Michael, et al.. (1999). Skin-prick blood samples are reliable for estimating Hb mass with the CO-dilution technique. European Journal of Applied Physiology. 79(6). 535–537. 9 indexed citations
19.
Ashenden, Michael, Christopher J. Gore, David T. Martin, Geoffrey P. Dobson, & Allan G. Hahn. (1999). Effects of a 12-day “live high, train low” camp on reticulocyte production and haemoglobin mass in elite female road cyclists. PubMed. 80(5). 472–478. 76 indexed citations
20.
Ashenden, Michael, et al.. (1998). Serum Ferritin and Anemia in Trained Female Athletes. International Journal of Sport Nutrition. 8(3). 223–229. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin Parisotto Breakdown of academic impact, for papers by C Howe Breakdown of academic impact, for papers by Fisher Jw Breakdown of academic impact, for papers by Linn Gillberg Breakdown of academic impact, for papers by Michael Walter Breakdown of academic impact, for papers by Adrian P. Trifa Breakdown of academic impact, for papers by H. Rochman Breakdown of academic impact, for papers by Ming Yu Breakdown of academic impact, for papers by Ehtesham Arif Breakdown of academic impact, for papers by Nancy Hua
Rankless by CCL
2026